AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CVS GROUP PLC

Transaction in Own Shares Jan 5, 2026

7590_pos_2026-01-05_886b78ae-882f-4f0f-a061-ae378efc328f.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5423N

CVS Group plc

05 January 2026

05 January 2026

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 02 January 2026 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase: 02/01/2026
Aggregate number of Ordinary Shares purchased: 15,144
Lowest price paid per share (GBp): 1,276.00
Highest price paid per share (GBp): 1,288.00
Volume weighted average price paid per share (GBp): 1,283.48

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,691,575 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 70,691,575 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 1,049,208 Ordinary Shares in aggregate at a weighted average price of 1,222.17 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of

Ordinary Shares purchased
Transaction price (GBp share) Time of

transaction (UK Time)
Transaction

reference number
Trading Venue
476 1286 02/01/2026 08:32:57 1363214713492077 XLON
68 1288 02/01/2026 08:36:55 1363214713492337 XLON
369 1288 02/01/2026 08:41:48 1363214713492824 XLON
100 1286 02/01/2026 08:50:09 1363214713493401 XLON
96 1286 02/01/2026 09:04:15 1363214713495427 XLON
68 1278 02/01/2026 09:40:47 1363214713497964 XLON
190 1280 02/01/2026 10:10:30 1363214713499744 XLON
255 1280 02/01/2026 10:10:30 1363214713499745 XLON
74 1278 02/01/2026 10:10:49 1363214713499776 XLON
100 1278 02/01/2026 10:10:49 1363214713499777 XLON
68 1278 02/01/2026 10:40:53 1363214713501159 XLON
390 1276 02/01/2026 12:51:49 1363214713506596 XLON
44 1276 02/01/2026 12:56:38 1363214713506780 XLON
48 1276 02/01/2026 12:56:38 1363214713506781 XLON
134 1276 02/01/2026 12:56:38 1363214713506782 XLON
185 1276 02/01/2026 13:00:42 1363214713506895 XLON
313 1276 02/01/2026 13:51:36 1363214713509932 XLON
100 1276 02/01/2026 13:51:36 1363214713509933 XLON
100 1276 02/01/2026 13:51:36 1363214713509931 XLON
17 1276 02/01/2026 13:51:36 1363214713509930 XLON
9 1276 02/01/2026 13:51:36 1363214713509929 XLON
179 1276 02/01/2026 13:51:36 1363214713509928 XLON
176 1276 02/01/2026 13:51:36 1363214713509934 XLON
176 1276 02/01/2026 13:51:36 1363214713509935 XLON
176 1276 02/01/2026 13:51:36 1363214713509936 XLON
126 1276 02/01/2026 13:51:36 1363214713509937 XLON
35 1276 02/01/2026 13:51:36 1363214713509938 XLON
161 1276 02/01/2026 13:51:36 1363214713509940 XLON
15 1276 02/01/2026 13:51:36 1363214713509939 XLON
176 1276 02/01/2026 13:51:36 1363214713509941 XLON
20 1276 02/01/2026 13:51:36 1363214713509942 XLON
156 1276 02/01/2026 13:51:36 1363214713509943 XLON
74 1276 02/01/2026 13:51:36 1363214713509944 XLON
86 1276 02/01/2026 13:51:36 1363214713509945 XLON
313 1276 02/01/2026 13:51:36 1363214713509947 XLON
16 1276 02/01/2026 13:51:36 1363214713509946 XLON
25 1276 02/01/2026 13:51:38 1363214713509952 XLON
55 1280 02/01/2026 14:28:25 1363214713512594 XLON
212 1284 02/01/2026 14:31:19 1363214713513356 XLON
3 1284 02/01/2026 14:46:05 1363214713516114 XLON
560 1284 02/01/2026 14:46:05 1363214713516115 XLON
381 1284 02/01/2026 14:56:31 1363214713517481 XLON
179 1284 02/01/2026 14:56:31 1363214713517482 XLON
411 1284 02/01/2026 15:01:46 1363214713518218 XLON
152 1284 02/01/2026 15:01:46 1363214713518219 XLON
200 1284 02/01/2026 15:12:32 1363214713519639 XLON
68 1284 02/01/2026 15:16:36 1363214713520188 XLON
576 1284 02/01/2026 15:24:08 1363214713521316 XLON
576 1284 02/01/2026 15:24:08 1363214713521317 XLON
431 1284 02/01/2026 15:38:58 1363214713522993 XLON
131 1284 02/01/2026 15:38:58 1363214713522994 XLON
103 1286 02/01/2026 15:48:01 1363214713523863 XLON
219 1286 02/01/2026 15:48:01 1363214713523862 XLON
170 1286 02/01/2026 15:48:01 1363214713523861 XLON
127 1286 02/01/2026 15:48:01 1363214713523860 XLON
176 1286 02/01/2026 15:48:01 1363214713523864 XLON
176 1286 02/01/2026 15:48:01 1363214713523865 XLON
176 1286 02/01/2026 15:48:01 1363214713523866 XLON
176 1288 02/01/2026 15:49:29 1363214713523986 XLON
176 1288 02/01/2026 15:49:29 1363214713523987 XLON
176 1288 02/01/2026 15:49:29 1363214713523988 XLON
176 1288 02/01/2026 15:49:29 1363214713523989 XLON
176 1288 02/01/2026 15:49:29 1363214713523990 XLON
176 1288 02/01/2026 15:49:29 1363214713523991 XLON
176 1288 02/01/2026 15:49:29 1363214713523992 XLON
27 1288 02/01/2026 15:49:29 1363214713523993 XLON
27 1288 02/01/2026 15:49:29 1363214713523995 XLON
149 1288 02/01/2026 15:49:29 1363214713523994 XLON
176 1288 02/01/2026 15:49:29 1363214713523996 XLON
176 1288 02/01/2026 15:49:29 1363214713523997 XLON
66 1288 02/01/2026 15:49:29 1363214713523998 XLON
569 1286 02/01/2026 15:49:29 1363214713524000 XLON
496 1284 02/01/2026 16:06:21 1363214713526638 XLON
89 1288 02/01/2026 16:23:18 1363214713529369 XLON
176 1288 02/01/2026 16:23:18 1363214713529370 XLON
176 1288 02/01/2026 16:23:18 1363214713529371 XLON
176 1288 02/01/2026 16:23:18 1363214713529372 XLON
4 1288 02/01/2026 16:23:18 1363214713529373 XLON
172 1288 02/01/2026 16:23:18 1363214713529374 XLON
77 1288 02/01/2026 16:23:18 1363214713529375 XLON
99 1288 02/01/2026 16:23:18 1363214713529376 XLON
176 1288 02/01/2026 16:23:18 1363214713529377 XLON
176 1288 02/01/2026 16:23:18 1363214713529378 XLON
176 1288 02/01/2026 16:23:18 1363214713529379 XLON
70 1288 02/01/2026 16:23:18 1363214713529380 XLON
176 1288 02/01/2026 16:23:18 1363214713529381 XLON
176 1288 02/01/2026 16:23:21 1363214713529406 XLON
111 1288 02/01/2026 16:23:22 1363214713529409 XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                  +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                             [email protected]

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSUPUMWGUPQGMP

Talk to a Data Expert

Have a question? We'll get back to you promptly.